In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

IPO on Nasdaq nets $9.8mm for Israel-based D Medical Industries

Executive Summary

Israeli device company D Medical Industries Ltd. has netted $9.8mm in its US initial public offering of 1.5mm ordinary shares at $7 each. The company, whose stock is already listed on the TASE, will now trade on Nasdaq.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
  • In Vitro Diagnostics
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register